Skip to content
Baret News – Lifestyle
Author:
Paradigm Therapeutics, Inc.
Paradigm Therapeutics, Inc. Nominated for the Second Straight Year for the Prestigious 2026 Prix Galien USA “Best Start-Up” Award for SD-101 (Zorblesia™), a Topical Therapy for Treating the Entire Skin Surface of Patients with Epidermolysis Bullosa (EB)
October 13, 2026